Guidance for lifestyle changes in patients with fatty liver disease
The Investigation of Different Guidance Methods to Facilitate Lifestyle Changes in Patients With NAFLD
This study is testing whether personalized lifestyle support from a dietitian or a digital app can help people with fatty liver disease improve their health better than regular care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Sex | All |
| Sponsor | Ziekenhuis Oost-Limburg Academic / other |
| Locations | 1 site (Genk, Limburg) |
| Trial ID | NCT05792488 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of lifestyle modification interventions, such as guidance from a dietitian or a digital application, compared to standard care for patients with Non-Alcoholic Fatty Liver Disease (NAFLD). Participants will receive tailored support aimed at improving their dietary habits and overall lifestyle to manage their condition. The study will measure outcomes based on FibroScan assessments to determine the impact of these interventions on liver health.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with NAFLD as determined by FibroScan measurements.
Not a fit: Patients with excessive alcohol use or other underlying liver diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved management and outcomes for patients with Non-Alcoholic Fatty Liver Disease.
How similar studies have performed: Other studies have shown promising results with lifestyle modification approaches for managing NAFLD, indicating potential for success in this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * NAFLD based in FibroScan measurements Exclusion Criteria: * excessive alcohol use * other causes of liver disease * secondary causes of liver steatosis
Where this trial is running
Genk, Limburg
- Ziekenhuis Oost-Limburg — Genk, Limburg, Belgium (Recruiting)
Study contacts
- Principal investigator: Geert Robaeys, MD. PhD — Hasselt University
- Study coordinator: Geert Robaeys, MD. PhD
- Email: nafldstudie@zol.be
- Phone: +32 89 21 20 55
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.